AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kidswell Bio Corporation

¥165 -$47.00 (-22.17%)
JPX · 15 Sep 2026 06:30 UTC
Previous Close
¥165
Day Range
¥165¥168
Year Range
¥125¥320
Market Cap
8.19B
AVG Volume
421.89K
Trailing/Forward PE
-21.71/8.55
PEG ratio
-0.41
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
Tokyo Stock ExchangeJP
Revenue (JPY)
01B2B3B23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Revenue (JPY) by quarter
PeriodRevenue (JPY)
26 Q11.27B
25 Q41.57B
25 Q31.74B
25 Q21.56B
25 Q11.72B
24 Q42.05B
24 Q31.29B
24 Q21.27B
24 Q1482M
23 Q4864.49M
Net Income (JPY)
-750M-500M-250M0250M23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Net Income (JPY) by quarter
PeriodNet Income (JPY)
26 Q1197.9M
25 Q4-271.19M
25 Q3-203.38M
25 Q2-96.54M
25 Q1157.13M
24 Q4166.63M
24 Q354.02M
24 Q2-65.1M
24 Q1-176.69M
23 Q4-674.68M
Operating Income (JPY)
-750M-500M-250M0250M23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Operating Income (JPY) by quarter
PeriodOperating Income (JPY)
26 Q1216.51M
25 Q4-222.59M
25 Q3-131.26M
25 Q230.68M
25 Q1184.65M
24 Q4165.79M
24 Q3124.62M
24 Q2-103.58M
24 Q1-158.94M
23 Q4-668.57M
EBITDA (JPY)
-750M-500M-250M0250M23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T EBITDA (JPY) by quarter
PeriodEBITDA (JPY)
26 Q1216.54M
25 Q4-222.53M
25 Q3-131.2M
25 Q2-80.04M
25 Q1185.23M
24 Q4151.2M
24 Q3182.8M
24 Q2-52.94M
24 Q1-164.8M
23 Q4-665.87M
EPS (JPY)
-20-1001023 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T EPS (JPY) by quarter
PeriodEPS (JPY)
26 Q13.9
25 Q4-5.54
25 Q3-4.1
25 Q2-1.95
25 Q13.28
24 Q43.96
24 Q31.33
24 Q2-1.6
24 Q1-4.49
23 Q4-17.51
Expenses (JPY)
0250M500M750M1BR&DSG&A23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Expenses (JPY) by quarter
PeriodExpenses (JPY)
26 Q1214.88M
25 Q4640M
25 Q3468.5M
25 Q2364.84M
25 Q1412.57M
24 Q4443.71M
24 Q3413.67M
24 Q2372.28M
24 Q1382.57M
23 Q4845.02M
Cash & Debt (JPY)
01B2B3B4BCashLong Term DebtShort Term Debt23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Cash & Debt (JPY) by quarter
PeriodCash & Debt (JPY)
26 Q13.23B
25 Q43.29B
25 Q33.78B
25 Q21.54B
25 Q12.84B
24 Q43B
24 Q31.32B
24 Q21.7B
24 Q11.17B
23 Q42.23B
Debt ratios
-10-50523 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Debt ratios by quarter
PeriodDebt ratios
26 Q13.49
25 Q43
25 Q3-9.27
25 Q2-0.93
25 Q1-2.77
24 Q4-9.96
24 Q3-1.02
24 Q2-0.52
24 Q1-1.14
23 Q4-0.25
Margins
0%20%40%60%23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Margins by quarter
PeriodMargins
26 Q133.98%
25 Q426.57%
25 Q319.35%
25 Q225.43%
25 Q134.71%
24 Q429.79%
24 Q341.84%
24 Q221.21%
24 Q146.4%
23 Q420.41%
Return on Capital
-100%-75%-50%-25%0%25%23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Return on Capital by quarter
PeriodReturn on Capital
26 Q110.77%
25 Q4-16.4%
25 Q3-10.56%
25 Q2-4.42%
25 Q17.67%
24 Q411.81%
24 Q35.13%
24 Q2-7.59%
24 Q1-24.75%
23 Q4-81.14%
Shares Outstanding
020M40M60M23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Shares Outstanding by quarter
PeriodShares Outstanding
26 Q149.63M
25 Q448.94M
25 Q349.6M
25 Q249.57M
25 Q141.92M
24 Q441.92M
24 Q340.67M
24 Q240.66M
24 Q139.32M
23 Q438.53M
Book Value Per Share (JPY)
020406023 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Book Value Per Share (JPY) by quarter
PeriodBook Value Per Share (JPY)
26 Q137.02
25 Q433.8
25 Q338.83
25 Q244.11
25 Q148.85
24 Q433.66
24 Q325.87
24 Q221.08
24 Q118.16
23 Q421.58
Total Assets (JPY)
02B4B6B8B23 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
4584.T Total Assets (JPY) by quarter
PeriodTotal Assets (JPY)
26 Q16.13B
25 Q46.09B
25 Q36.32B
25 Q25.82B
25 Q16.58B
24 Q47.01B
24 Q34.57B
24 Q24.65B
24 Q14.61B
23 Q45.09B
PE Ratio
0200400600med 45.82Oct 25Nov 25Jan 26Feb 26Apr 26May 26Jun 26
4584.T PE Ratio by quarter
PeriodPE Ratio
Jun 26283.07
Jun 26283.07
Jun 26280.99
Jun 26293.48
May 26324.7
May 26387.15
May 26418.37
May 26468.32
May 26472.48
Apr 26478.73
Apr 26520.36
Apr 26514.11
Apr 26516.19
Mar 2644.24
Mar 2644.41
Mar 2646.88
Mar 2648.29
Feb 2648.29
Feb 2645.82
Feb 2646.18
Feb 2643.18
Jan 2643.18
Jan 2653.23
Jan 2645.82
Jan 2641.24
Dec 2535.78
Dec 2527.49
Dec 2527.08
Dec 2528.02
Dec 2529.1
Nov 2533.39
Nov 2531.51
Nov 2535.26
Nov 2532.85
Oct 2533.92
Oct 2533.65
Oct 2532.85
Oct 2535.53
Oct 2532.58
Price to Sales
01234med 1.58Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
4584.T Price to Sales by quarter
PeriodPrice to Sales
Sep 261.23
Sep 261.21
Sep 261.22
Aug 261.34
Aug 261.26
Aug 261.21
Aug 261.09
Jul 261.09
Jul 261.05
Jul 261.08
Jul 261.11
Jul 261.16
Jun 260.95
Jun 260.95
Jun 260.95
Jun 260.99
May 261.1
May 261.31
May 261.41
May 261.58
May 261.59
Apr 261.61
Apr 261.76
Apr 261.73
Apr 261.74
Mar 261.88
Mar 261.89
Mar 262
Mar 262.06
Feb 262.06
Feb 261.95
Feb 261.97
Feb 261.84
Jan 261.84
Jan 262.27
Jan 261.95
Jan 261.76
Dec 251.52
Dec 251.36
Dec 251.34
Dec 251.39
Dec 251.44
Nov 251.65
Nov 251.56
Nov 251.74
Nov 251.63
Oct 251.68
Oct 251.67
Oct 251.63
Oct 251.76
Oct 251.61
Sep 252.29
Sep 252.26
Sep 252.13
Sep 252.32
Aug 252.1
Aug 252.08
Aug 252.65
Aug 252.16
Aug 252.16
Jul 252.24
Jul 252.15
Jul 252.07
Jul 251.91
Jun 252.98
Jun 253.86
Jun 253.16
Jun 252.43
May 252.23
May 251.85
May 251.59
May 251.32
May 251.31
Apr 251.37
Apr 251.51
Apr 251.2
Apr 251.14
Mar 251.38
Mar 251.49
Mar 251.55
Mar 251.45
Feb 251.67
Feb 251.74
Feb 251.28
Feb 251.23
Jan 251.21
Jan 251.2
Jan 251.2
Jan 251.2
Dec 241.24
Dec 241.49
Dec 241.43
Dec 241.58
Dec 241.6
Nov 241.7
Nov 241.66
Nov 241.51
Nov 241.54
Nov 241.49
Oct 241.51
EV/EBITDA
0255075100125med 38.69Jul 25Sep 25Nov 25Jan 26Mar 26May 26Jun 26
4584.T EV/EBITDA by quarter
PeriodEV/EBITDA
Jun 2644.62
Jun 2644.62
Jun 2644.23
Jun 2646.61
May 2652.55
May 2664.44
May 2670.38
May 2679.89
May 2680.68
Apr 2681.87
Apr 2689.8
Apr 2688.61
Apr 2689
Mar 2627.4
Mar 2627.51
Mar 2629.09
Mar 2630
Feb 2630
Feb 2628.42
Feb 2628.64
Feb 2626.72
Jan 2626.72
Jan 2633.16
Jan 2628.42
Jan 2625.48
Dec 2521.98
Dec 2515.66
Dec 2515.39
Dec 2516.02
Dec 2516.74
Nov 2519.62
Nov 2518.36
Nov 2520.88
Nov 2519.26
Oct 2519.98
Oct 2519.8
Oct 2519.26
Oct 2521.06
Oct 2519.08
Sep 2590.29
Sep 2588.85
Sep 2583.08
Sep 2591.37
Aug 2582
Aug 2580.91
Aug 25105.79
Aug 2584.52
Aug 2584.52
Jul 2588.13
Jul 2584.16
Jul 2580.55
Jul 2573.7
Price to Book
051015med 5.7Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
4584.T Price to Book by quarter
PeriodPrice to Book
Sep 264.88
Sep 264.82
Sep 264.85
Aug 265.36
Aug 265.03
Aug 264.82
Aug 264.35
Jul 264.35
Jul 264.2
Jul 264.32
Jul 264.44
Jul 264.62
Jun 263.5
Jun 263.5
Jun 263.48
Jun 263.63
May 264.02
May 264.79
May 265.18
May 265.79
May 265.85
Apr 265.92
Apr 266.44
Apr 266.36
Apr 266.39
Mar 265.69
Mar 265.71
Mar 266.03
Mar 266.21
Feb 266.21
Feb 265.89
Feb 265.94
Feb 265.55
Jan 265.55
Jan 266.85
Jan 265.89
Jan 265.31
Dec 254.6
Dec 254.2
Dec 254.14
Dec 254.28
Dec 254.44
Nov 255.1
Nov 254.81
Nov 255.38
Nov 255.02
Oct 255.18
Oct 255.14
Oct 255.02
Oct 255.42
Oct 254.97
Sep 258.26
Sep 258.14
Sep 257.67
Sep 258.35
Aug 257.58
Aug 257.49
Aug 259.54
Aug 257.78
Aug 257.78
Jul 258.08
Jul 257.75
Jul 257.46
Jul 256.89
Jun 2511.05
Jun 2514.3
Jun 2511.71
Jun 259.01
May 258.27
May 256.84
May 255.88
May 254.91
May 254.87
Apr 255.06
Apr 255.6
Apr 254.44
Apr 254.21
Mar 255.79
Mar 256.26
Mar 256.5
Mar 256.07
Feb 257.02
Feb 257.3
Feb 255.36
Feb 255.17
Jan 255.08
Jan 255.03
Jan 255.03
Jan 255.03
Dec 245.22
Dec 246
Dec 245.73
Dec 246.33
Dec 246.44
Nov 246.83
Nov 246.66
Nov 246.06
Nov 246.17
Nov 246
Oct 246.06
Kidswell Bio Corporation
4584.T
Stockpicker

Video analysis: 4584.T

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.